Early Life
Jiang Rensheng was born in China and began his career as a primary school teacher. He later became a government health official, gaining experience in the healthcare sector. These early experiences laid the foundation for his future entrepreneurial success.
Rise to Success
Jiang founded Zhifei Biological Products Co. This company focused on vaccine development and quickly became a key player in the pharmaceutical industry. The company's shares surged in June 2020 after the approval of clinical human testing for a COVID-19 vaccine, increasing Jiang's fortune substantially. Zhifei went public in 2010 on the Shenzhen Stock Exchange.
Key Business Strategies
Jiang's leadership has been instrumental in Zhifei's growth. The company has focused on research, development, and the production of vaccines for diseases such as the flu, meningitis, and HPV. Jiang secured a distribution contract with Merck for the HPV vaccine, marking a significant milestone. Zhifei has also diversified its activities to include R&D, production, marketing, distribution, import, and export of biotech products and services. In 2023, Jiang took his antibody drug maker Chongqing Genrix Biopharmaceutical public on the Shanghai Stock Exchange.
Philanthropy
Jiang and his company have made charitable contributions. He donated RMB 10 million to Hubei province for pandemic control and regularly contributes to various associations, rural schools, and university libraries. He upholds a philosophy of 'social benefits go before corporate profits.'
